VentriPoint Historical Cash Flow

Stocks . Canada . 
Stock . VentriPoint Diagnostics
VPT Stock  CAD 0.17  0.01  6.25%   
Analysis of VentriPoint Diagnostics cash flow over time is an excellent tool to project VentriPoint Diagnostics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 427.5 K or Begin Period Cash Flow of 6.3 M as it is a great indicator of VentriPoint Diagnostics ability to facilitate future growth, repay debt on time or pay out dividends.
   Cash Flow   Balance Sheet   Income Statement
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining VentriPoint Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether VentriPoint Diagnostics is a good buy for the upcoming year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VentriPoint Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About VentriPoint Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in VentriPoint balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which VentriPoint's non-liquid assets can be easily converted into cash.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Financial
Indicators
Details
Valuation
Indicators
Details

VentriPoint Diagnostics Cash Flow Chart

At this time, VentriPoint Diagnostics' Change In Working Capital is fairly stable compared to the past year. Begin Period Cash Flow is likely to climb to about 6.3 M in 2025, whereas Free Cash Flow is likely to drop (3.6 M) in 2025.
End Period Cash Flow  Stock Based Compensation  
Add Fundamental

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.
Most accounts from VentriPoint Diagnostics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into VentriPoint Diagnostics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VentriPoint Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, VentriPoint Diagnostics' Change In Working Capital is fairly stable compared to the past year. Begin Period Cash Flow is likely to climb to about 6.3 M in 2025, whereas Free Cash Flow is likely to drop (3.6 M) in 2025.
 2022 2023 2024 2025 (projected)
Stock Based Compensation798.1K493.3K567.3K378.4K
Depreciation50.9K66.7K76.7K45.9K

VentriPoint Diagnostics cash flow statement Correlations

Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Non Cash Items
Capital Expenditures
Net Income
End Period Cash Flow
Depreciation
Stock Based Compensation
Sale Purchase Of Stock
Change To Inventory
Net Borrowings
Change To Account Receivables
Change To Operating Activities
Change To Netincome
Change To Liabilities
Investments
Issuance Of Capital Stock
Change In Cash
0.29-0.49-0.67-0.180.140.30.55-0.250.16-0.11-0.38-0.04-0.10.09-0.04-0.07-0.230.89
Free Cash Flow
0.29-0.06-0.590.22-0.210.86-0.29-0.47-0.53-0.62-0.18-0.070.04-0.290.22-0.1-0.140.04
Change In Working Capital
-0.49-0.060.06-0.24-0.13-0.01-0.620.48-0.360.110.340.290.570.15-0.230.410.2-0.57
Begin Period Cash Flow
-0.67-0.590.060.25-0.38-0.70.240.470.480.440.590.18-0.040.120.30.040.6-0.45
Other Non Cash Items
-0.180.22-0.240.25-0.19-0.180.03-0.090.130.240.15-0.03-0.010.030.81-0.40.05-0.18
Capital Expenditures
0.14-0.21-0.13-0.38-0.190.0-0.22-0.27-0.23-0.01-0.58-0.35-0.16-0.08-0.42-0.19-0.640.12
Net Income
0.30.86-0.01-0.7-0.180.0-0.39-0.58-0.64-0.71-0.35-0.050.01-0.44-0.280.03-0.330.11
End Period Cash Flow
0.55-0.29-0.620.240.03-0.22-0.390.170.760.320.130.15-0.250.230.26-0.040.350.66
Depreciation
-0.25-0.470.480.47-0.09-0.27-0.580.170.470.570.450.60.120.360.070.410.64-0.24
Stock Based Compensation
0.16-0.53-0.360.480.13-0.23-0.640.760.470.60.340.33-0.10.460.21-0.130.310.31
Sale Purchase Of Stock
-0.11-0.620.110.440.24-0.01-0.710.320.570.60.30.360.050.670.19-0.040.18-0.15
Change To Inventory
-0.38-0.180.340.590.15-0.58-0.350.130.450.340.30.410.610.180.32-0.140.55-0.32
Net Borrowings
-0.04-0.070.290.18-0.03-0.35-0.050.150.60.330.360.410.240.15-0.140.210.28-0.09
Change To Account Receivables
-0.10.040.57-0.04-0.01-0.160.01-0.250.12-0.10.050.610.240.12-0.02-0.29-0.04-0.1
Change To Operating Activities
0.09-0.290.150.120.03-0.08-0.440.230.360.460.670.180.150.120.2-0.13-0.07-0.1
Change To Netincome
-0.040.22-0.230.30.81-0.42-0.280.260.070.210.190.32-0.14-0.020.2-0.330.37-0.1
Change To Liabilities
-0.07-0.10.410.04-0.4-0.190.03-0.040.41-0.13-0.04-0.140.21-0.29-0.13-0.330.45-0.03
Investments
-0.23-0.140.20.60.05-0.64-0.330.350.640.310.180.550.28-0.04-0.070.370.45-0.16
Issuance Of Capital Stock
0.890.04-0.57-0.45-0.180.120.110.66-0.240.31-0.15-0.32-0.09-0.1-0.1-0.1-0.03-0.16
Click cells to compare fundamentals

VentriPoint Diagnostics Account Relationship Matchups

High Positive Relationship

Issuance Of Capital Stock
+ 0.89
Change In Cash
Net Income
+ 0.86
Free Cash Flow
Change To Netincome
+ 0.81
Other Non Cash Items
Stock Based Compensation
+ 0.76
End Period Cash Flow
Change To Operating Activities
+ 0.67
Sale Purchase Of Stock
Issuance Of Capital Stock
+ 0.66
End Period Cash Flow

High Negative Relationship

Sale Purchase Of Stock
- 0.71
Net Income
Net Income
- 0.7
Begin Period Cash Flow
Begin Period Cash Flow
- 0.67
Change In Cash
Stock Based Compensation
- 0.64
Net Income
Investments
- 0.64
Capital Expenditures
End Period Cash Flow
- 0.62
Change In Working Capital

VentriPoint Diagnostics cash flow statement Accounts

202020212022202320242025 (projected)
Change In Cash512.3K8.7M(4.1M)(3.9M)(3.5M)(3.3M)
Free Cash Flow(1.1M)(3.2M)(4.1M)(3.8M)(3.4M)(3.6M)
Change In Working Capital123.0K(462.6K)(331.1K)452.4K407.1K427.5K
Begin Period Cash Flow13.8K526.0K9.3M5.2M6.0M6.3M
Other Cashflows From Financing Activities1.7M1.1M3.9M(24.5K)(28.1K)(26.7K)
Other Non Cash Items204.4K(26.5K)218.2K308.3K354.6K372.3K
Total Cash From Operating Activities(1.1M)(3.1M)(4.1M)(3.8M)(3.4M)(3.6M)
Net Income(1.9M)(3.9M)(4.9M)(4.9M)(4.4M)(4.2M)
Total Cash From Financing Activities1.6M11.9M87.6K(102.4K)(117.7K)(111.8K)
End Period Cash Flow526.0K9.3M5.2M1.3M1.5M1.5M
Depreciation54.9K48.8K50.9K66.7K76.7K45.9K
Stock Based Compensation394.8K898.3K798.1K493.3K567.3K378.4K
Change To Inventory38.2K30.8K32.2K176.7K203.2K213.3K
Change To Account Receivables(97.7K)(32.2K)(176.7K)88.7K102.0K107.1K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for VentriPoint Stock Analysis

When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY